The Ras-association domain family (RASSF) members and their role in human tumourigenesis.
Ras proteins play a direct causal role in human cancer with activating mutations in Ras occurring in approximately 30% of tumours. Ras effectors also contribute to cancer, as mutations occur in Ras effectors, notably B-Raf and PI3-K, and drugs blocking elements of these pathways are in clinical development. In 2000, a new Ras effector was identified, RAS-association domain family 1 (RASSF1), and expression of the RASSF1A isoform of this gene is silenced in tumours by methylation of its promoter. Since methylation is reversible and demethylating agents are currently being used in clinical trials, detection of RASSF1A silencing by promoter hypermethylation has potential clinical uses in cancer diagnosis, prognosis and treatment. RASSF1A belongs to a new family of RAS effectors, of which there are currently 8 members (RASSF1-8). RASSF1-6 each contain a variable N-terminal segment followed by a Ras-association (RA) domain of the Ral-GDS/AF6 type, and a specialised coiled-coil structure known as a SARAH domain extending to the C-terminus. RASSF7-8 contain an N-terminal RA domain and a variable C-terminus. Members of the RASSF family are thought to function as tumour suppressors by regulating the cell cycle and apoptosis. This review will summarise our current knowledge of each member of the RASSF family and in particular what role they play in tumourigenesis, with a special focus on RASSF1A, whose promoter methylation is one of the most frequent alterations found in human tumours.
van der Weyden
Louise
L
Experimental Cancer Genetics Laboratory, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton Cambridge, UK. lvdw@sanger.ac.uk
Adams
David J
DJ
D000818:Animals; D019175:DNA Methylation; D015972:Gene Expression Regulation, Neoplastic; D020868:Gene Silencing; D011905:Genes, ras / Q000502:physiology*; D006801:Humans; D009369:Neoplasms / Q000235:genetics / Q000473:pathology*; D025521:Tumor Suppressor Proteins / Q000502:physiology*
C411762:RASSF1 protein, human; D025521:Tumor Suppressor Proteins
Br J Cancer. 2004 Aug 16;91(4):771-4
15266335
Cancer Res. 2004 Sep 15;64(18):6476-81
15374957
Oncol Rep. 2004 Oct;12(4):781-7
15375500
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6119-25
15447998
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6189-93
15448006
J Biochem. 1999 Nov;126(5):799-803
10544270
J Biol Chem. 1999 Dec 31;274(53):37538-43
10608806
Curr Opin Cell Biol. 2000 Feb;12(1):52-6
10679354
Cancer Res. 2000 Apr 1;60(7):1949-60
10766185
Nat Genet. 2000 Jul;25(3):315-9
10888881
Oncogene. 2000 Aug 10;19(34):3948-54
10951588
Biochem J. 2000 Oct 15;351 Pt 2:289-305
11023813
Methods Enzymol. 2000;327:331-50
11044995
J Biol Chem. 2003 Jun 13;278(24):21938-43
12676952
Oncogene. 2003 Jun 12;22(24):3806-12
12802288
Cancer Res. 2003 Jul 1;63(13):3743-6
12839968
J Biol Chem. 2003 Jul 25;278(30):28045-51
12732644
Nat Immunol. 2003 Aug;4(8):741-8
12845325
Oncogene. 2001 Nov 8;20(51):7573-7
11709729
Cancer Res. 2001 Dec 15;61(24):8659-63
11751381
J Med Genet. 2002 Feb;39(2):98-104
11836357
Am J Pathol. 2002 Feb;160(2):605-12
11839581
Clin Cancer Res. 2002 Feb;8(2):514-9
11839671
Oncogene. 2002 Feb 21;21(9):1381-90
11857081
Curr Biol. 2002 Feb 19;12(4):253-65
11864565
Am J Pathol. 2002 Mar;160(3):787-94
11891177
Oncogene. 2002 Apr 18;21(17):2713-20
11965544
Cancer Res. 2002 May 1;62(9):2715-20
11980673
Mol Cell Biol. 2002 Jun;22(12):4309-18
12024041
Oncogene. 2002 May 23;21(23):3792-5
12032847
Cancer Res. 2002 Jun 15;62(12):3498-502
12067994
Oncogene. 2002 Jun 20;21(27):4340-4
12082623
Oncogene. 2002 Jun 20;21(27):4345-9
12082624
Oncogene. 2002 Jul 4;21(29):4521-9
12085230
Cancer Res. 2002 Jul 1;62(13):3698-701
12097277
Clin Cancer Res. 2002 Jul;8(7):2362-8
12114441
Mol Carcinog. 2002 Oct;35(2):85-92
12325038
Oncogene. 2002 Oct 3;21(44):6835-40
12360410
Mol Cancer Ther. 2001 Nov;1(1):61-7
12467239
Oncogene. 2003 Jan 9;22(1):147-50
12527916
Nature. 2003 Jan 16;421(6920):231-7
12529635
J Biol Chem. 2006 Mar 24;281(12):8143-52
16421102
Oncogene. 2006 Mar 23;25(13):1984-8
16288222
Oncol Rep. 2006 May;15(5):1281-5
16596198
Gastroenterology. 2006 Apr;130(4):1117-28
16618406
Methods Enzymol. 2006;407:290-310
16757333
In Vitro Cell Dev Biol Anim. 2002 Nov-Dec;38(10):582-94
12762840
Int J Cancer. 2003 Jul 20;105(6):851-5
12767073
Int J Cancer. 2003 Aug 10;106(1):45-51
12794755
Curr Biol. 2006 Dec 19;16(24):2459-65
17174922
Nucleic Acids Res. 2007 Jan;35(Database issue):D610-7
17148474
Cancer Res. 2007 Jan 15;67(2):492-500
17234756
Cancer Res. 2007 Feb 1;67(3):1054-61
17283138
Clin Cancer Res. 2007 Feb 1;13(3):944-52
17289889
Clin Cancer Res. 2003 Aug 1;9(8):2981-4
12912945
Cancer Res. 2003 Sep 1;63(17):5344-51
14500366
Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3635-40
14506151
Neoplasia. 2003 Jul-Aug;5(4):362-6
14511407
Int J Cancer. 2003 Nov 20;107(4):612-6
14520700
Oncogene. 2003 Oct 2;22(43):6794-801
14555992
Cancer Res. 2003 Oct 1;63(19):6206-11
14559805
Oncogene. 2003 Nov 6;22(50):8125-36
14603253
N Engl J Med. 2003 Nov 20;349(21):2042-54
14627790
Cancer Res. 2003 Nov 15;63(22):7641-5
14633683
Mutat Res. 2003 Nov;544(2-3):403-13
14644343
Curr Biol. 2003 Dec 2;13(23):R899-900
14654011
Oncogene. 2003 Dec 8;22(56):9075-86
14663486
Cancer Cell. 2003 Nov;4(5):405-13
14667507
Cancer Res. 2003 Dec 15;63(24):8695-9
14695183
In Silico Biol. 2003;3(3):235-40
12954087
Cancer Res. 2004 Jan 1;64(1):102-7
14729613
Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):28-32
14734448
Proc Natl Acad Sci U S A. 1994 May 24;91(11):5124-8
8197195
JAMA. 1995 Feb 15;273(7):558-63
7837389
Curr Biol. 1995 Sep 1;5(9):973-6
8542286
Cancer Res. 1996 Apr 1;56(7):1487-92
8603390
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9821-6
8790415
Oncogene. 2003 Feb 13;22(6):947-54
12584574
Int J Cancer. 2003 May 1;104(5):611-6
12594816
Histol Histopathol. 2003 Apr;18(2):665-77
12647816
Int J Cancer. 2003 Jun 10;105(2):204-9
12673680
Cancer Res. 2003 Apr 15;63(8):1888-93
12702579
Int J Cancer. 2004 May 10;109(6):839-47
15027117
Cancer Lett. 2004 Mar 18;205(2):181-8
15036650
Cancer. 2004 Apr 1;100(7):1472-7
15042681
Clin Cancer Res. 2004 Mar 15;10(6):1887-93
15041703
Oncogene. 2004 Mar 25;23(13):2408-19
14743209
Clin Cancer Res. 2004 Apr 1;10(7):2284-8
15073103
Oncogene. 2004 Apr 22;23(19):3426-33
15007383
Prostate. 2004 Jun 15;60(1):25-31
15129426
Clin Cancer Res. 2004 May 1;10(9):3104-9
15131050
Oncogene. 2004 May 13;23(22):4014-22
15064737
Cell Cycle. 2004 May;3(5):574-6
15107619
Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):882-8
15159323
Cancer Res. 2004 Jun 15;64(12):4112-6
15205320
Cancer Res. 2004 Jun 15;64(12):4244-50
15205337
Biochem J. 2004 Jul 15;381(Pt 2):453-62
15109305
Cancer Res. 2004 Jul 1;64(13):4585-92
15231670
J Biol Chem. 2004 Jul 9;279(28):29247-54
15075335
Trends Cell Biol. 2004 Jul;14(7):331-4
15246424
Ann N Y Acad Sci. 2004 Jun;1022:217-20
15251963
Mol Cancer. 2004 Feb 23;3:6
14977426
J Biol Chem. 2004 Jul 23;279(30):31318-28
15145946
BMC Microbiol. 2004 Jul 15;4:28
15256003
Oncogene. 2004 Aug 5;23(35):5941-9
15208682
Nat Immunol. 2004 Oct;5(10):1045-51
15361866
Oncogene. 2004 Oct 28;23(50):8216-30
15378022
Cancer Res. 1977 Mar;37(3):646-50
837366
Oncology. 1989;46(5):318-22
2779946
Cell. 1990 Aug 10;62(3):503-14
1974172
Proc Natl Acad Sci U S A. 1990 Aug;87(16):6117-21
2385586
Oncogene. 1992 Oct;7(10):1989-97
1408139
Genomics. 1992 Oct;14(2):309-19
1339391
Carcinogenesis. 2007 Jun;28(6):1364-70
17183069
Int J Oncol. 2007 Jul;31(1):169-73
17549418
Cell Cycle. 2007 Jul 1;6(13):1663-5
17598981
Oncogene. 2007 Sep 13;26(42):6203-11
17404571
Oncogene. 2007 Dec 6;26(55):7700-8
17563743
Cancer Res. 1996 Nov 1;56(21):5044-6
8895762
Trends Biochem Sci. 1996 Nov;21(11):422-5
8987396
Adv Cancer Res. 1997;71:27-92
9111863
J Biol Chem. 1998 Mar 6;273(10):5439-42
9488663
Curr Opin Genet Dev. 1998 Feb;8(1):49-54
9529605
Oncogene. 1998 Jun 18;16(24):3151-7
9671394
Biochim Biophys Acta. 1998 Aug 19;1378(1):F21-59
9739759
Oncogene. 1999 Jan 21;18(3):643-50
9989814
Oncogene. 2004 Nov 11;23(53):8695-9
15378027
Clin Cancer Res. 2004 Nov 15;10(22):7457-65
15569975
Cancer Res. 2004 Dec 1;64(23):8688-93
15574778
Clin Cancer Res. 2004 Dec 15;10(24):8472-8
15623627
Cancer Res. 2005 Jan 1;65(1):92-8
15665283
Clin Cancer Res. 2005 Jan 1;11(1):166-72
15671542
J Biol Chem. 2005 Feb 4;280(5):3920-7
15546880
J Biol Chem. 2005 Feb 11;280(6):5022-31
15569673
Cancer Res. 2005 Feb 15;65(4):1141-5
15734995
Histol Histopathol. 2005 Apr;20(2):645-63
15736067
Cancer Res. 2000 Nov 1;60(21):6116-33
11085536
J Biol Chem. 2000 Nov 17;275(46):35669-72
10998413
Mamm Genome. 2001 Feb;12(2):150-6
11210185
Curr Opin Genet Dev. 2001 Feb;11(1):83-90
11163156
Oncogene. 2001 Mar 22;20(12):1509-18
11313894
J Natl Cancer Inst. 2001 May 2;93(9):691-9
11333291
Cancer Res. 2001 May 15;61(10):3877-81
11358799
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7504-9
11390984
Cancer Res. 2001 Sep 15;61(18):6688-92
11559536
Cancer Res. 2001 Oct 1;61(19):7034-8
11585730
Am J Pathol. 2007 Mar;170(3):941-50
17322379
Ann Oncol. 2007 Mar;18(3):491-7
17170014
Cell. 2007 Feb 23;128(4):683-92
17320506
Dis Markers. 2007;23(1-2):73-87
17325427
Lung Cancer. 2007 Apr;56(1):1-7
17194498
Clin Cancer Res. 2007 Mar 15;13(6):1720-5
17363525
Prostate. 2007 May 1;67(6):638-44
17342751
Endocr Relat Cancer. 2007 Mar;14(1):125-34
17395981
Int J Cancer. 2007 May 15;120(10):2191-5
17285579
Exp Cell Res. 2007 Apr 15;313(7):1484-95
17367779
Curr Biol. 2007 Apr 17;17(8):700-5
17379520
Lung Cancer. 2007 May;56(2):289-94
17267069
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9236-41
17517604
Cancer Res. 2005 Mar 1;65(5):1830-8
15753381
Lab Invest. 2005 Apr;85(4):464-73
15711568
Nature. 2005 Mar 24;434(7032):462-9
15791247
Cancer Res. 2005 Apr 1;65(7):2690-7
15805267
J Mol Biol. 2005 May 6;348(3):741-58
15826668
J Mol Biol. 2005 May 6;348(3):759-75
15826669
Int J Cancer. 2005 Jul 1;115(4):575-81
15700308
J Clin Oncol. 2005 May 1;23(13):2903-10
15753461
Cancer Res. 2005 May 1;65(9):3682-90
15867363
Clin Cancer Res. 2005 Jun 1;11(11):4097-106
15930345
Oncogene. 2005 Jun 2;24(24):3987-94
15806169
Int J Oncol. 2005 Jul;27(1):185-91
15942659
Mol Cell. 2005 Jun 10;18(6):637-50
15949439
Brief Bioinform. 2005 Jun;6(2):189-93
15975227
J Bone Miner Res. 2005 Aug;20(8):1430-9
16007340
Gastroenterology. 2005 Jul;129(1):156-69
16012945
Cancer. 2005 Aug 15;104(4):771-6
15959912
Lab Invest. 2005 Sep;85(9):1065-75
15980887
Mol Cell Biol. 2005 Sep;25(18):8356-67
16135822
Cancer Res. 2005 Sep 1;65(17):7653-9
16140931
Immunology. 2005 Oct;116(2):164-71
16162265
Clin Cancer Res. 2005 Sep 15;11(18):6505-11
16166426
Clin Cancer Res. 2005 Nov 1;11(21):7728-34
16278393
Mod Pathol. 2005 Dec;18(12):1632-40
16258509
Br J Cancer. 2005 Dec 12;93(12):1395-9
16265349
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D227-30
16381852
J Biol Chem. 2006 Feb 24;281(8):4557-63
16344548
J Clin Endocrinol Metab. 2006 Mar;91(3):1143-9
16352687
J Hepatol. 2006 Jul;45(1):81-9
16516329
BMC Cancer. 2006;6:89
16606445
J Pathol. 2006 Jul;209(3):336-43
16639696
Oncogene. 2006 Jun 29;25(28):3934-8
16462760
EMBO J. 2006 Jul 26;25(14):3286-97
16810318
Cell Signal. 2006 Oct;18(10):1647-54
16520020
Nat Immunol. 2006 Sep;7(9):919-28
16892067
BMC Cancer. 2006;6:254
17064406
Int J Cancer. 2007 Jan 1;120(1):32-8
17013896
Int J Cancer. 2007 Jan 1;120(1):7-12
17013898
Am J Physiol Lung Cell Mol Physiol. 2006 Dec;291(6):L1185-90
16891396
Oncol Res. 2006;16(4):205-9
17120618
Ann N Y Acad Sci. 2006 Sep;1076:810-21
17119258
Rocz Akad Med Bialymst. 2003;48:34-41
14737938
J Pathol. 2004 Feb;202(2):233-40
14743506
Hum Genet. 2004 Feb;114(3):272-9
14605870
Nat Genet. 2004 Feb;36(2):117-8
14752520
Nat Cell Biol. 2004 Feb;6(2):129-37
14743218
Clin Cancer Res. 2004 Feb 1;10(3):994-1002
14871978
Int J Cancer. 2004 Apr 10;109(3):377-84
14961576
Oncogene. 2004 Feb 12;23(6):1326-31
14961078
Cancer Res. 2004 Mar 1;64(5):1664-8
14996725
Cancer Res. 2004 Mar 15;64(6):1975-86
15026333